We get the rundown on mRNA vaccine manufacturing. How were the vaccines developed so quickly?

Manufacturers have a unique opportunity to take advantage of the cost and time advantages associated with Oligo(dT) – the adoption process is simple.

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

What’s all this talk of cancer vaccines? We find out how they work – and how mRNA has boosted the field – with the help of five experts.

With mRNA offering more straightforward development and manufacturing processes, are the days of traditional vaccine modalities numbered?

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.

Why is self-amplifying mRNA gaining more and more attention in the vaccine space?

Our eBook features mRNA vs malaria, vaccines, top tips for mRNA sequencing, and more